selectION Announces Positive Results from Phase 1b Clinical Trial Evaluating si-544 in Patients with Atopic Dermatitis
April 29, 2024 04:00 ET
|
AKAMPION
si-544 was well tolerated with no serious adverse effects, dose limiting toxicities, or safety signals observed75% of patients receiving si-544 experienced objective clinical improvement, of which 44%...
Global Thin and Ultrathin Films Markets Report 2024: A $38.8 Billion Market by 2028, Driven by Rising Demand for Compound Semiconductor Material and Increasing Application of Epitaxial Layers
April 29, 2024 03:41 ET
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global Markets, Technologies and Materials for Thin and Ultrathin Films" report has been added to ResearchAndMarkets.com's offering.The global market...
GXO Completes Acquisition of Wincanton
April 29, 2024 03:26 ET
|
GXO Logistics
GREENWICH, Conn., April 29, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced that, effective today, it has completed its...
Continuous Glucose Monitoring Market to hit USD 20 Bn by 2032, says Global Market Insights Inc.
April 29, 2024 02:20 ET
|
Global Market Insights Inc.
Selbyville, Delaware, April 29, 2024 (GLOBE NEWSWIRE) -- Continuous Glucose Monitoring Market Size is projected to accrue over USD 20 billion in revenue by 2032. The increasing prevalence of...
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
April 29, 2024 01:00 ET
|
Addex Therapeutics
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...
Dimethyl Carbonate Market worth $1.9 billion by 2028, at a CAGR of 12.7%, says MarketsandMarkets™
April 28, 2024 21:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 28, 2024 (GLOBE NEWSWIRE) -- The Dimethyl Carbonate Market is projected to grow from USD 1.1 billion in 2023 to USD 1.9 billion by 2028, at a CAGR of 12.7% from 2023 to 2028, as per...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm
April 28, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, April 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Checkpoint, Sonder, Perion, and Autodesk and Encourages Investors to Contact the Firm
April 28, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, April 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Actuators Market Size, Share, Industry Growth & Analysis, 2029
April 28, 2024 20:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 28, 2024 (GLOBE NEWSWIRE) -- The Actuators Market Size is projected to grow from USD 67.7 Billion in 2024 to USD 94.8 Billion by 2029, at a CAGR of 7.0% during the forecast period....
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with Losses to Contact the Firm
April 28, 2024 20:17 ET
|
Schall Law
The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with Losses to Contact the Firm